Search Within

Larry Norton

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (16)
  2. Meeting Abstract (11)
  3. Editorial (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (28)
  2. Breast Medicine Service (28)
  3. Department of Medicine (28)
  4. Molecular Pharmacology and Chemistry Program Faculty (28)
  5. Sloan Kettering Institute Faculty (28)
  6. Solid Tumor Oncology Division (28)

More Groups

People
  1. Neal Rosen (19)
  2. Clifford Hudis (11)
  3. David Solit (11)
  4. Shanu Modi (11)
  5. Sarat Chandarlapaty (10)
  6. Sujata Patil (6)

More People

Years
  1. 2023 (1)
  2. 2021 (2)
  3. 2020 (1)
  4. 2019 (2)
  5. 2018 (1)
  6. 2016 (1)

More Years

Publications
  1. Clinical Cancer Research (8)
  2. Cancer Research (4)
  3. Journal of Clinical Oncology (3)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (2)
  5. Annals of Oncology (1)
  6. Breast Cancer Research and Treatment (1)

More Publications

Publishers
  1. American Association for Cancer Research (14)
  2. Nature Publishing Group (4)
  3. American Society of Clinical Oncology (3)
  4. Cell Press (2)
  5. Elsevier Inc. (1)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (28)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Modulation of Hsp90 function by ansamycins enhances chemotherapy induced apoptosis in breast cancer cell lines in an RB and schedule dependent manner
    Meeting Abstract

    Munster, P. N.; Basso, A. D.; Solit, D.; Norton, L.; Scher, H.; Rosen, N.
    Proceedings of the American Association for Cancer Research Annual Meeting (2001)

    Fulltext@MSK | Save
  • 17-Allylamino-geldanamycin causes AKT inactivation and enhances the anti-tumor effects of paclitaxel
    Meeting Abstract

    Solit, D. B.; Basso, A. D.; Munster, P. N.; Norton, L.; Scher, H. I.; Rosen, N.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Modulation of Hsp90 function by ansamycins sensitizes breast cancer cells to chemotherapy-induced apoptosis in an RB- and schedule-dependent manner. See: The Biology Behind: E. A. Sausville, Combining cytotoxics and 17-allylamino, 17-demethoxygeldanamycin: Sequence and tumor biology matters. Clin. Cancer Res., 7: 2155-2158, 2001
    Journal Article

    Munster, P. N.; Basso, A.; Solit, D.; Norton, L.; Rosen, N.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: A phase I trial
    Journal Article

    Gilewski, T.; Ragupathi, G.; Bhuta, S.; Williams, L. J.; Musselli, C.; Zhang, X. F.; Bencsath, K. P.; Panageas, K. S.; Chin, J.; Hudis, C. A.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2001)

    Fulltext@MSK | Save
  • 17-allyl-amino-seldanamycin induces HER2 degradation and AKT inactivation in a human breast cancer xenograft model
    Meeting Abstract

    Solit, D.; Munster, P.; Basso, A.; Tong, W.; Agus, D.; Scher, H.; Norton, L.; Rosen, N.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • Farnesyltransferase inhibitor (FTI) and EGF receptor (EGFR) blockade induced a synergistic G(1) arrest in H-Ras-transformed human breast epithelial cells
    Meeting Abstract

    Chou, J. L.; Moasser, M.; Sepp-Lorenzino, L.; Mendelsohn, J.; Norton, L.; Rosen, N.
    Proceedings of the American Association for Cancer Research Annual Meeting (1999)

    Fulltext@MSK | Save
  • Refining the origins of breast cancer
    Journal Article

    Norton, L.; Rosen, P. P.; Rosen, N.
    Nature Medicine (1995)

    Fulltext@MSK | Save
  • Modeling the development of metastases from primary and locally recurrent tumors: Comparison with a clinical data base for prostatic cancer
    Journal Article

    Yorke, E. D.; Fuks, Z.; Norton, L.; Whitmore, W.; Ling, C. C.
    Cancer Research (1993)

    Fulltext@MSK | Save